Assessment of semen parameters and Anti-müllerian hormone level in patients with chronic kidney disease on hemodialysis: a case control study
1Andrology, Sexology and STDS Department, Faculty of Medicine, Suez Canal University, 41511 Ismailia, Egypt
2Ministry of Health and Population, Etsa Medical Center, 63759 Fayoum, Egypt
3Clinical Pathology Department, Faculty of Medicine, Suez Canal University, 41511 Ismailia, Egypt
4Andrology, Infertility and STDS Department, Faculty of Medicine, Suez Canal University, 41511 Ismailia, Egypt
DOI: 10.31083/jomh.2021.074 Vol.17,Issue 4,September 2021 pp.72-77
Submitted: 28 April 2021 Accepted: 02 July 2021
Published: 30 September 2021
Background and objective: Chronic kidney disease (CKD) is a common health problem which is accompanied by considerable morbidity and mortality. Anti-müllerian hormone (AMH) is one of the hormones that are affected by CKD. The objective was to assess semen parameters and AMH level in CKD patients on hemodialysis.
Material and methods: This study was a case control study of 20 patients with stage 4 and 5 CKD on hemodialysis, attending Nephrology Outpatient Clinic and Renal Dialysis Unit of Suez Canal University hospital and 20 healthy fertile controls. Full history, clinical examination, kidney function tests and semen analysis were performed. AMH level in serum and seminal plasma was measured using ELISA.
Results: The mean AMH level in serum of case group was 3.35 ± 2.43 ng/mL versus 4.13 ± 3.17 ng/mL in the controls respectively (p > 0.05) while mean AMH level in semen of the case group was 2.13 ± 2.64 ng/mL compared to 9.37 ± 3.79 ng/mL in controls respectively (p < 0.05). There was a positive correlation between AMH in seminal plasma and sperm count, total sperm motility, progressive sperm motility and sperm viability, while the AMH level in serum was insigniﬁcantly related.
Conclusion: Semen parameters in CKD patients on hemodialysis were signiﬁcantly poorer than normal controls AMH in seminal plasma was signiﬁcantly decreased in CKD patients (stage 4–5 on hemodialysis) and signiﬁcantly correlated with the semen parameters.
CKD; Serum AMH; Seminal AMH; Semen parameters
Rashad Mostafa,Ghada M. Soliman,Amal F. Abd Alhai,Mohamed Azab. Assessment of semen parameters and Anti-müllerian hormone level in patients with chronic kidney disease on hemodialysis: a case control study. Journal of Men's Health. 2021. 17(4);72-77.
 Levin A, Stevens PE, Bilous RW, Coresh J, De Francisco ALM, De Jong PE, et al. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International Supplements. 2013; 3: 1–150.
 Webster AC, Nagler EV, Morton RL, Masson P. Chronic Kidney Disease. Lancet. 2017; 389: 1238–1252.
 Eckersten D, Giwercman A, Bruun L, Christensson A. Anti-Müllerian hormone, a Sertoli cell-derived marker, is decreased in plasma of male patients in all stages of chronic kidney disease. Andrology. 2016; 3: 1160–1164.
 Palmer BF, Clegg DJ. Gonadal dysfunction in chronic kidney disease. Reviews in Endocrine & Metabolic Disorders. 2017; 18: 117–130.
 Lundy SD, Vij SC. Male infertility in renal failure and transplantation. Translational Andrology and Urology. 2020; 8: 173–181.
 Silva GP, Grangeiro VPX, Carneiro FP. Grangeiro, Seminal Ferritin And Seminal Parameters In Patients Undergoing Chronic Hemodialy-sis. International Archives of Medicine. 2017; 10.
 Xu HM, Li HG, Xu L, Zhang J, Chen W, Shi Q. The decline of fertility in male uremic patients is correlated with low expression of the cystic fibrosis transmembrane conductance regulator protein (CFTR) in human sperm. Human Reproduction. 2012; 27: 340–348.
 McLennan IS, Pankhurst MW. Anti-Müllerian hormone is a gonadal cytokine with two circulating forms and cryptic actions. Journal of Endocrinology. 2015; 226: R45–R57.
 MacLaughlin DT, Donahoe PK. Sex determination and differentiation. New England Journal of Medicine. 2004; 350: 367–378.
 Sriraman V, Niu E, Matias JR, Donahoe PK, MacLaughlin DT, Hardy MP, et al. Müllerian inhibiting substance inhibits testosterone synthesis in adult rats. Journal of Andrology. 2002; 22: 750–758.
 Eckersten D, Giwercman A, Christensson A. Male patients with terminal renal failure exhibit low serum levels of antimüllerian hormone. Asian Journal of Andrology. 2016; 17: 149–153.
 Xu H, Zhang M, Zhang H, Alpadi K, Wang L, Li R, et al. Clinical Applications of Serum Anti-Müllerian Hormone Measurements in both Males and Females: an Update. Innovation. 2021; 2: 100091.
 Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney International. 2011; 80: 17–28.
 Tocci A, Lucchini C. Who reference values for human semen. Human Reproduction Update. 2010; 16: 559.
 Lehtihet M, Hylander B. Semen quality in men with chronic kidney disease and its correlation with chronic kidney disease stages. Andrologia. 2016; 47: 1103–1108.
 Holley JL, Schmidt RJ. Changes in fertility and hormone replacement therapy in kidney disease. Advances in Chronic Kidney Disease. 2013; 20: 240–245.
 Josso N, Rey R, Picard J. Testicular Anti-Müllerian hormone: clinical applications in DSD. Seminars in Reproductive Medicine. 2013; 30: 364–373.
 Sinisi AA, Esposito D, Maione L, Quinto MC, Visconti D, De Bellis A, et al. Seminal Anti-Müllerian hormone level is a marker of spermatogenic response during long-term gonadotropin therapy in male hypogonadotropic hypogonadism. Human Reproduction. 2008; 23: 1029–1034.
 Trbovich AM, Sluss PM, Laurich VM, O’Neill FH, MacLaughlin DT, Donahoe PK, et al. Müllerian Inhibiting Substance lowers testosterone in luteinizing hormone-stimulated rodents. Proceedings of the National Academy of Sciences of the United States of America. 2001; 98: 3393–3397.
 Prem AR, Punekar SV, Kalpana M, Kelkar AR, Acharya VN. Male reproductive function in uraemia: efficacy of haemodialysis and renal transplantation. British Journal of Urology. 1996; 78: 635–638.
 Eckersten D, Tsatsanis C, Giwercman A, Bruun L, Pihlsgård M, Christensson A. MicroRNA-155 and Anti-Müllerian Hormone: New Potential Markers of Subfertility in Men with Chronic Kidney Disease. Nephron Extra. 2019; 7: 33–41.
 Aksglaede L, Olesen IA, Carlsen E, Petersen JH, Juul A, Jørgensen N. Serum concentration of Anti-Müllerian hormone is not associated with semen quality. Andrology. 2018; 6: 286–292.
 Andersen JM, Herning H, Witczak O, Haugen TB. Anti-Müllerian hormone in seminal plasma and serum: association with sperm count and sperm motility. Human Reproduction. 2016; 31: 1662–1667.
 Kucera R, Ulcova-Gallova Z, Windrichova J, Losan P, Topolcan O. Anti-Müllerian hormone in serum and seminal plasma in comparison with other male fertility parameters. Systems Biology in Reproductive Medicine. 2017; 62: 223–226.
 Al-Qahtani A, Muttukrishna S, Appasamy M, Johns J, Cranfield M, Visser JA, et al. Development of a sensitive enzyme immunoassay for anti‐Müllerian hormone and the evaluation of potential clinical applications in males and females. Clinical Endocrinology. 2005; 63: 267–273.
Science Citation Index Expanded Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.
Social Sciences Citation Index Social Sciences Citation Index contains over 3,400 journals across 58 social sciences disciplines, as well as selected items from 3,500 of the world’s leading scientific and technical journals. More than 9.37 million records and 122 million cited references date back from 1900 to present.
Current Contents - Social & Behavioral Sciences Current Contents - Social & Behavioral Sciences provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in the social and behavioral sciences.
Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.
SCOPUS Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.
DOAJ DOAJ is a community-curated online directory that indexes and provides access to high quality, open access, peer-reviewed journals.
CrossRef Crossref makes research outputs easy to find, cite, link, assess, and reuse. Crossref committed to open scholarly infrastructure and collaboration, this is now announcing a very deliberate path.
Portico Portico is a community-supported preservation archive that safeguards access to e-journals, e-books, and digital collections. Our unique, trusted process ensures that the content we preserve will remain accessible and usable for researchers, scholars, and students in the future.